CEO Jean Jacques Bienaime sold $2.3M of BioMarin Pharmaceutical Inc.

Sold$2,330,700

$77.69Price

30,000Shares

−5%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Thu, Mar 10. Filed Mon, Mar 14, 8:44 PM ET, after the close. Not investment advice.